Journals / Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.) / 2008 / Cilt: 19 - Sayı: 2

Prostaglandin E2 ve hyaluronik asit sıçan dizinde oluşturulan osteokondral defektlerin onarımında etkilidir

Prostaglandin E2 and hyaluronic acid facilitates treatment of osteochondral deffects

Pages
78–83
Publication Date
2022-10-18
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

These properties of PGE2 and hyaluronic acid will have a role during the development of new strategies in osteochondral defect treatment.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objectives: Restoration of the articular hyaline cartilage is the basic prerequisite to preserve normal function of the synovial joint after injury.
📊
Key Findings & Data:We have assumed combining hyaluronic acid with prostaglandin E2 (PGE2) will enhance hyaline cartilage formation by stimulating mesenchymal stem cells on fibrin clot scaffold.
💡
Conclusion & Impact:These properties of PGE2 and hyaluronic acid will have a role during the development of new strategies in osteochondral defect treatment.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Objectives: Restoration of the articular hyaline cartilage is the basic prerequisite to preserve normal function of the synovial joint after injury. We have assumed combining hyaluronic acid with prostaglandin E2 (PGE2) will enhance hyaline cartilage formation by stimulating mesenchymal stem cells on fibrin clot scaffold. Material and methods: Rat knee joint osteochondral defects were treated by (a) bone marrow on fibrin clot, (b) hyaluronic acid alone, © bone marrow on fibrin clot combined with PGE2, (d) bone marrow on fibrin clot combined with hyaluronic acid, (e) bone marrow on fibrin clot with hyaluronic acid and PGE2, and (f) a control group left without treatment.Results: Evaluations were carried out at week six in all groups by radiology and histology. Coverage of defective area with various grades of fibrous or hyaline cartilage was noticed in all groups. All treatment groups presented better healing patterns than the control group. Hyaline cartilage with normal matrix staining pattern was observed on Safranin-O stained sections from (1) bone marrow on fibrin clot with PGE2 and (2) bone marrow on fibrin clot with hyaluronic acid and PGE2. Healing response at these groups was statistically better then the control group.Conclusion: This study demonstrates beneficial effects of PGE2 and hyaluronic acid during chondrocyte differentiation. These properties of PGE2 and hyaluronic acid will have a role during the development of new strategies in osteochondral defect treatment.

Özet

korunabilmesi açısından gereklidir. Bu çalışmada hyaluronik asit ve Prostaglandin E2’ nin (PGE2) birlikte kullanılmasının fibrin pıhtı içerine emdirilmiş kemik iliği hücrelerinden hyaline kıkırdak dokusunun gelişmesini uyarabileceği varsayımını araştırdık. Gereç ve yöntemler: Sıçan dizlerinde oluşturulan osteokondral lezyonlar belirlen çalışma protokollerine uygun olarak tedavi edildi. Buna göre gruplar; (1) kemik iliği ve fibrin pıhtı karışımı, (2) sadece hyaluronik asit, (3) fibrin pıhtı, kemik iliği ve PGE2, (4) fibrin pıhtı, kemik iliği ve hyaluronik asit (5) fibrin pıhtı, kemik iliği karışımı ile hyaluronik asit PGE2 karışımı, (6) tedavi verilmeyen kontrol grubu olarak belirlendi. Altıncı haftanın sonunda çalışma sonuçları histolojik olarak değerlendirildi.Sonuçlar: Tüm tedavi gruplarında kontrol grubundan belirgin olarak farklı derecelerde fibröz ve hyaline kıkırdak iyileşmesi saptandı. Fibrin pıhtı, kemik iliği ve hyaluronik asit karışımın kullanıldığı grup ile fibrin pıhtı, kemik iliği karışımı ile hyaluronik asit ve PGE2’nin birlikte kullanıldığı gruplarda Safranin-O ile boyanmış kesitlerde normal hyalin kıkırdak ağ yapısı ile aynı boyama özellikleri gösteren kıkırdak matriksin oluştuğu görüldü. Bu bulgu konrol grubundan anlamlı (p

🔖

Cite This Article

KORKUSUZ, F., KORKUSUZ, P., AKTEKİN, C. N., TABAK, A. Y., BİRİNCİ, B., ÖZTÜRK, A. M. (2022). Prostaglandin E2 ve hyaluronik asit sıçan dizinde oluşturulan osteokondral defektlerin onarımında etkilidir. Eklem Hastalıkları ve Cerrahisi Dergisi (Eski Adı: Artroplasti Artroskopik Cerrahi Derg.), Cilt: 19 - Sayı: 2, 78–83. https://ajindex.com/articles/498787

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Meyer U, Wiesman HP. Bone and Cartilage Engineering. Berlin Heidelberg: Springer-Verlag; 2006
  2. Koulalis D, Schultz W, Heyden M, Konig F. Autologous osteochondral grafts in the treatment of cartilage defects of the knee joint. Knee Surg Sports Traumatol Arthrosc. Jul 2004;12:329-34
  3. Fulkerson JP, Damiano P. Effect of prostaglandin E2 on adult pig articular cartilage slices in culture. Clin Orthop Relat Res. Oct 1983;179:266-69
  4. Martin I, Miot S, Barbero A, Jakob M, WendIvan D. Osteochondral tissue engineering. Journal of Biomechanics 2007;40:750-65
  5. Pineda S, Pollack A, Stevenson S, Goldberg V, Caplan A. A semiquantitative scale for histologic grading of articular cartilage repair. Acta Anat (Basel). 1992;143:335-40
  6. Del Toro F, Jr., Sylvia VL, Schubkegel SR, et al. Characterization of prostaglandin E(2) receptors and their role in 24,25- (OH)(2)D(3)-mediated effects on resting zone chondrocytes. J Cell Physiol. 2000;182:196-208
  7. Boie Y, Stocco R, Sawyer N, et al. Molecular cloning and characterization of the four rat prostaglandin E2 prostanoid receptor subtypes. Eur J Pharmacol. 1997;340:227-41
  8. Katsuyama M, Nishigaki N, Sugimoto Y, et al. The mouse prostaglandin E receptor EP2 subtype: cloning, expression, and northern blot analysis. FEBS Lett. 1995;372:151-56
  9. An S, Yang J, Xia M, Goetzl EJ. Cloning and expression of the EP2 subtype of human receptors for prostaglandin E2. Biochem Biophys Res Commun. 1993;197:263-70
  10. Bastien L, Sawyer N, Grygorczyk R, Metters KM, Adam M. Cloning, functional expression, and characterization of the human prostaglandin E2 receptor EP2 subtype. J Biol Chem. 1994;269:11873-7
  11. Aoyama T, Liang B, Okamoto T, et al. PGE2 signal through EP2 promotes the growth of articular chondrocytes. J Bone Miner Res. 2005;20:377-89
  12. Miyamoto M, Ito H, Mukai S, et al. Simultaneous stimulation of EP2 and EP4 is essential to the effect of prostaglandin E2 in chondrocyte differentiation. Osteoarthritis Cartilage. 2003;11:644-52
  13. Clark CA, Schwarz EM, Zhang X, et al. Differential regulation of EP receptor isoforms during chondrogenesis and chondrocyte maturation. Biochem Biophys Res Commun. Mar 18 2005;328(3):764-776
  14. Narumiya S, Sugimoto Y, Ushikubi F. Prostanoid receptors: structures, properties, and functions. Physiol Rev. 1999;79:1193- 226
  15. Pavesio A, Abatangelo G, Borrione A, et al. Hyaluronan-based scaffolds (Hyalograft C) in the treatment of knee cartilage defects: preliminary clinical find